Barrington Research Maintains Outperform on Merit Medical Systems, Lowers Price Target to $107
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and lowers the price target from $109 to $107.
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and lowers the price target from $109 to $107.